Biohaven Pharmaceutical Holding - M&A Summary, Ownership, and Business Overview

Life ScienceCompany

Biohaven Pharmaceutical Holding M&A Summary

Biohaven Pharmaceutical Holding has acquired 1 company of its own, including 1 in the last 5 years.

Biohaven Pharmaceutical Holding’s largest acquisition to date was in 2022, when it acquired Channel Biosciences for $100M. Biohaven Pharmaceutical Holding has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).

Biohaven Pharmaceutical Holding Ownership

Who owns Biohaven Pharmaceutical Holding?

Biohaven Pharmaceutical Holding is owned by Pfizer. It was acquired on May 10, 2022.

Biohaven Pharmaceutical Holding Business Overview

Where is Biohaven Pharmaceutical Holding headquartered?

Biohaven Pharmaceutical Holding is headquartered in New Haven, Connecticut.

What is Biohaven Pharmaceutical Holding’s revenue?

Biohaven Pharmaceutical Holding disclosed revenue of 463M USD for 2021 and 64M USD for 2020.

How many employees does Biohaven Pharmaceutical Holding have?

Biohaven Pharmaceutical Holding has 928 employees.

What sector is Biohaven Pharmaceutical Holding in?

Biohaven Pharmaceutical Holding is a life science company.

When was Biohaven Pharmaceutical Holding founded?

Biohaven Pharmaceutical Holding was founded in 2013.

M&A Summary

  • M&A Total Activity1
    • M&A Buy Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 1

Biohaven Pharmaceutical Holding

Biohaven Pharmaceutical Holding Co. Ltd.

215 Church Street,
New Haven, Connecticut 06510
United States,
(203) 404-0410
www.biohavenpharma.com

Biohaven Pharmaceutical Holding is a biopharmaceutical company engaged in the identification and development of clinical-stage compounds targeting orphan neurologic indications and other neurological pathways. Biohaven Pharmaceutical Holding was incorporated in 2013 and is based in New Haven, Connecticut.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.2/yr) # - - - 1 - - 1
vol $100M $100M
Sell (0.0/yr) # - - - - - - 0
  1

Most Recent M&A

Company Date Value Type
Channel Biosciences LLC 2022-02-25 100M USD Divestiture
Pittsburgh, Pennsylvania
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 1 (100%) 100M (100%) - -
Total 1 $100M - -

By Geo

State/Country Buy Value Sell Value
United States 1 100M - -
  Pennsylvania 1 100M - -
Total 1 $100M - -

Deal Values

buy # Total
< $100M 1 $100M
TOTAL $100M
Largest Channel Biosciences LLC
$100M (2022-02-25)

M&A Connections

Deals
Acquired from
Strategic(s)
100%
1 (100%)

 Subscribe to unlock this and 208,055
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.